Document:

Officers' Certificate

 EXHIBIT 4.2 
 UNIVERSAL HEALTH SERVICES, INC. 
 OFFICERS’ CERTIFICATE 
 The undersigned do hereby certify, pursuant to Sections 2.1, 2.3 and 13.5 of the indenture, dated as of January 20, 2000 (the “Base
Indenture”) as amended by a supplemental indenture, dated as of June 20, 2006 (the “Supplemental Indenture,” and together with the Base Indenture, the “Indenture”), by and between Universal Health
Services, Inc., a Delaware corporation (the “Company”) and J.P. Morgan Trust Company, National Association (as successor to Bank One Trust Company, N.A.), as trustee (the “Trustee”), that the Pricing Committee of
the Board of Directors of the Company has determined, by unanimous written consent on June 27, 2006, pursuant to the authority granted by the Board of Directors of the Company on June 19, 2006, that the terms of a series of securities to
be issued under the Indenture are as follows: 
 1. The securities of such series shall be known and designated as the 7.125% Notes due 2016
(“Notes”) of the Company. 
 2. The aggregate principal amount of Notes which may be authenticated and delivered under the
Indenture is initially limited to $250,000,000, subject to increase in any reopening of the series as provided in Section 2.3 the Indenture. 
 3. The Notes will mature on June 30, 2016. 
 4. The Notes shall bear interest at the rate of 7.125% per annum, payable
semiannually on June 30 and December 30 of each year (each, an “Interest Payment Date”), commencing December 30, 2006, from the most recent Interest Payment Date to which interest has been paid or, if no interest has
been paid, from June 30, 2006, until payment of the principal sum has been made or duly provided for. 
 5. The principal of and on the
Notes shall be payable in immediately available funds in such coin or currency of the United States of America as at the time of payment shall be legal tender for the payment of public and private debts, at the office or agency of the Company
maintained for such purpose in the City of New York. Interest on the Notes shall be paid at such office or agency, in like coin or currency; provided, that payment of interest may be made at the option of the Company by check mailed to the address
of the person entitled thereto as such address shall appear on the security register. 
 6. The amount of interest payable on any Interest
Payment Date shall be computed on the basis of a 360-day year of twelve 30-day months. Each payment of interest in respect of an Interest Payment Date shall include interest accrued 

 through the day prior to such Interest Payment Date. The interest so payable on any Interest Payment Date will, subject
to the exceptions provided in the Indenture, be paid to the persons in whose names the Notes are registered at the close of business on the June 15 or December 15, preceding the respective Interest Payment Dates (except that interest
payable at maturity shall be paid to the same persons to whom principal of the Notes is payable whether or not such day is a Business Day (as defined in the Indenture). 
 7. The Company shall issue and sell $250,000,000 aggregate principal amount of the Notes to Banc of America Securities LLC and J.P. Morgan Securities Inc., as representatives (the “Representatives”)
of the underwriters named in Schedule II to the Underwriting Agreement, dated June 27, 2006, by and among the Company and the Representatives, at a purchase price of 7.125% per Note. 
 8. The Notes shall be issued as a Global Security in substantially the form attached hereto as Exhibit A. The Depository Trust Company shall be
the Depositary. 
 9. The Notes may be redeemed, in whole at any time or in part from time to time, at the option of the Company, at a
redemption price equal to accrued and unpaid interest on the principal amount being redeemed to the redemption date plus the greater of: 
 (a) 100% of the principal amount of the Notes to be redeemed; and 
 (b) the sum of the
present values of the remaining scheduled payments of principal and interest on the Notes to be redeemed (not including any portion of such payments of interest accrued to the date of redemption) discounted to the date of redemption on a semiannual
basis (assuming a 360-day year consisting of twelve 30-day months) at the Adjusted Treasury Rate, plus 30 basis points. 
 “Adjusted
Treasury Rate” means, with respect to any date of redemption, the rate per year equal to the semiannual equivalent yield to maturity of the Comparable Treasury Issue, assuming a price for the Comparable Treasury Issue (expressed as a
percentage of its principal amount) equal to the Comparable Treasury Price for that date of redemption. 
 “Comparable Treasury
Issue” means the United States Treasury security selected by the Quotation Agent as having a maturity comparable to the remaining term of the Notes to be redeemed that would be used, at the time of selection and under customary financial
practice, in pricing new issues of corporate debt securities of comparable maturity to the remaining term of the Notes. 
  

 2 

 “Comparable Treasury Price” means, with respect to any date of redemption, the average
of the Reference Treasury Dealer Quotations for the date of redemption, after excluding the highest and lowest Reference Treasury Dealer Quotations, or if the Trustee is provided fewer than three Reference Treasury Dealer Quotations, the average of
all Reference Treasury Dealer Quotations. 
 “Quotation Agent” means Banc of America Securities LLC or another Reference
Treasury Dealer appointed by the Company. 
 “Reference Treasury Dealer” means each of Banc of America Securities LLC and
J.P. Morgan Securities Inc. and their respective successors and any other primary treasury dealer selected by the Company. If any of the foregoing ceases to be a primary U.S. Government securities dealer in New York City, the Company must substitute
another primary treasury dealer. 
 “Reference Treasury Dealer Quotations” means, with respect to each Reference Treasury
Dealer and any date of redemption, the average of the bid and asked prices for the Comparable Treasury Issue (expressed in each case as a percentage of its principal amount) quoted in writing to the Trustee and the Company by the Reference Treasury
Dealer at 5:00 p.m., New York City time, on the third business day before the date of redemption. 
 Notice of any redemption will be mailed at least 30 days
but not more than 60 days before the date of redemption to each holder of the Notes to be redeemed. Unless the Company defaults in payment of the redemption price, on and after the date of redemption, interest will cease to accrue on the Notes or
portions of the Notes called for redemption. 
 10. For purposes of the Notes: 
 “Below Investment Grade Rating Event” means the Notes are rated below Investment Grade (as defined below) by both Rating Agencies (as
defined below) on any date from the date of the public notice of an arrangement that could result in a Change of Control (as defined below) until the end of the 60-day period following public notice of the occurrence of a Change of Control (which
period shall be extended so long as the rating of the Notes is under publicly announced consideration for possible downgrade by either of the Rating Agencies). 
 “Capital Stock” means any and all shares, interests, participations or other equivalents (however designated) of capital stock of a corporation, any and all equivalent ownership interests in a person
(other than a corporation) and any and all warrants or options to purchase any of the foregoing. 
  

 3 

 “Change of Control” means the occurrence of any of the following: 
  

	 	(1)	the direct or indirect sale, transfer, conveyance or other disposition (other than by way of merger or consolidation), in one or a series of related transactions, of all or
substantially all of the Company’s properties or assets and those of the Company’s subsidiaries, taken as a whole, to any “person” (as that term is used in Section 13(d)(3) of the Securities Exchange Act of 1934, as amended
(the “Exchange Act”)), other than the Company or one of its wholly owned subsidiaries; 

  

	 	(2)	the adoption of a plan relating to the Company’s liquidation or dissolution; 

  

	 	(3)	the consummation of any transaction (including, without limitation, any merger or consolidation) the result of which is that any “person” (as that term is used in
Section 13(d)(3) of the Exchange Act), other than the Company, one of its wholly owned subsidiaries or any person who holds more than 50% of the Company’s Voting Stock (as defined below) as of the date of the final prospectus supplement
for the Notes or any member of his, her or its immediate family (as that term is defined in Rule 16a-1(e) of the Exchange Act) (provided that this exception does not include any transaction in which public stockholders cease to own Voting Stock
entitling public stockholders to elect the same percentage of the members of the Company’s board of directors as public stockholders are entitled to elect on the date of the final prospectus supplement for the Notes), becomes the beneficial
owner, directly or indirectly, of more than 50% of the Company’s Voting Stock, measured by voting power rather than number of shares; or 

  

	 	(4)	the first day on which a majority of the members of the Company’s board of directors are not Continuing Directors (as defined below). 

 Notwithstanding the foregoing, a transaction effected to create a holding company for the Company will not be deemed to involve a Change of Control if
(1) pursuant to such transaction the Company becomes a wholly owned subsidiary of such holding company and (2) the holders of the Voting Stock of such holding company 
  

 4 

 immediately following such transaction are the same as the holders of the Company’s Voting Stock
immediately prior to such transaction. 
 “Change of Control Repurchase Event” means the occurrence of a Change of Control
and a Below Investment Grade Rating Event. 
 “Continuing Directors” means, as of any date of determination, any member of
the Company’s board of directors who: 
  

	 	(1)	was a member of the Company’s board of directors on the first date that any of the Notes were issued; or 

  

	 	(2)	was nominated for election or elected to the Company’s board of directors with the approval of a majority of the Continuing Directors who were members of the Company’s
board of directors at the time of such nomination or election. 

 “Investment Grade” means a rating of Baa3 or
better by Moody’s (as defined below) (or its equivalent under any successor rating categories of Moody’s) and BBB-or better by S&P (as defined below) (or its equivalent under any successor rating categories of S&P) (or, in each
case, if such Rating Agency ceases to rate the Notes for reasons outside of the Company’s control, the equivalent investment grade credit rating from any Rating Agency selected by the Company as a replacement Rating Agency). 
 “Moody’s” means Moody’s Investors Service, Inc. 
 “Rating Agency” means: 
  

	 	(1)	each of Moody’s and S&P; and 

  

	 	(2)	if either of Moody’s or S&P ceases to rate the Notes or fails to make a rating of the Notes publicly available for reasons outside of the Company’s control, a
“nationally recognized statistical rating organization” within the meaning of Rule 15c3-1(c)(2)(vi)(F) under the Exchange Act selected by the Company as a replacement agency for Moody’s or S&P, or both, as the case may be.

 “S&P” means Standard & Poor’s Ratings Services, a division of The McGraw-Hill Companies,
Inc. 
 “Voting Stock” as applied to stock of any person, means shares, interests, participations or other equivalents in the
equity interest (however designated) in such person having ordinary voting power 
  

 5 

 for the election of a majority of the directors (or the equivalent) of such person, other than shares,
interests, participations or other equivalents having such power only by reason of the occurrence of a contingency. 
 If a Change of Control
Repurchase Event occurs, unless the Company has exercised its right to redeem the Notes as described in paragraph 9 above, the Company will make an offer to each holder of Notes to repurchase all or any part (in multiples of $1,000 principal amount)
of that holder’s Notes at a repurchase price in cash equal to 101% of the aggregate principal amount of the Notes repurchased plus any accrued and unpaid interest on the Notes repurchased to the date of repurchase. Within 30 days following any
Change of Control Repurchase Event or, at the Company’s option, prior to any Change of Control, but after the public announcement of the Change of Control, the Company will mail a notice to each holder describing the transaction or transactions
that constitute or may constitute the Change of Control Repurchase Event and offering to repurchase Notes on the payment date specified in the notice, which date will be no earlier than 30 days and no later than 60 days from the date such notice is
mailed. The notice shall, if mailed prior to the date of consummation of the Change of Control, state that the offer to repurchase is conditioned on the Change of Control Repurchase Event occurring on or prior to the payment date specified in the
notice. 
 The Company will comply with the requirements of Rule 14e-1 under the Exchange Act and any other securities laws and regulations to
the extent those laws and regulations are applicable in connection with the repurchase of the Notes as a result of a Change of Control Repurchase Event. To the extent that the provisions of any securities laws or regulations conflict with the Change
of Control Repurchase Event provisions of the Notes, the Company will comply with the applicable securities laws and regulations and will not be deemed to have breached its obligations under the Change of Control Repurchase Event provisions of the
Notes by virtue of such conflict. 
 On the Change of Control Repurchase Event payment date, the Company will, to the extent lawful:

  

	 	(1)	accept for payment all Notes or portions of Notes properly tendered pursuant to the Company’s offer; 

  

 6 

	 	(2)	deposit with the paying agent an amount equal to the aggregate purchase price in respect of all Notes or portions of Notes properly tendered; and 

  

	 	(3)	deliver or cause to be delivered to the Trustee the Notes properly accepted, together with an officers’ certificate stating the aggregate principal amount of Notes being
purchased by the Company. 

 The paying agent will promptly pay, from funds deposited by the Company for such purpose, to each
holder of Notes properly tendered the purchase price for the Notes, and the Trustee will promptly authenticate and mail (or cause to be transferred by book-entry) to each holder a new Note equal in principal amount to any unpurchased portion of any
Notes surrendered. 
 The Company will not be required to make an offer to repurchase the Notes upon a Change of Control Repurchase Event if a
third party makes an offer in the manner, at the times and otherwise in compliance with the requirements for an offer made by the Company and such third party purchases all Notes properly tendered and not withdrawn under its offer; and further

 We have read Sections 2.1, 2.3 and 13.5 of the Indenture and the definitions in the Indenture relating thereto. The statements made herein
are based either upon our personal knowledge or on information, data and reports furnished to us by the officers, counsel or employees of the Company who have knowledge of the relevant facts. 
 In our opinion, we have made such examination or investigation as is necessary to enable us to express an informed opinion as to whether or not all
conditions provided for in the Indenture with respect to the terms of the Notes and the authentication and delivery of the Notes have been complied with. 
 In our opinion, all conditions precedent to the determination of the terms and form of the Notes and to the authentication by the Trustee of $250,000,000 principal amount thereof have been complied with and such Notes
may be authenticated and delivered in accordance with the Indenture. 
  

 7 

 IN WITNESS WHEREOF, we have executed this Certificate on behalf of the Company on this 30th day of June, 2006. 
  

			
	UNIVERSAL HEALTH SERVICES, INC.
		
	By:	 	/s/ Steve Filton
	Name:	 	Steve Filton
	Title:	 	Senior Vice President, Chief Financial Officer and Secretary
		
	By:	 	/s/ Cheryl K. Ramagano
	Name:	 	Cheryl K. Ramagano
	Title:	 	Treasurer

  

 8Form of Stock Appreciation Rights Agreement

 Exhibit 10.1 
 CDI Corp. 
 STOCK APPRECIATION RIGHTS AGREEMENT 
 1. Grant of SAR’s. The Company hereby grants to [name of recipient] (the “Recipient”)
[number] stock appreciation rights (the “SAR’s”). This grant is subject to the terms, definitions and provisions of the Plan, which is incorporated herein by reference. In the event of a conflict between
the terms of this Agreement and the Plan, the Plan will prevail. 
 2. Definitions. 
 (a) “Board” means the Board of Directors of CDI Corp. 
 (b) “Cause” shall have the same meaning as is set forth in an employment agreement, engagement agreement, “covenants and agreements” or similar document between the Recipient and the Company. If
there is no such agreement or document, then Cause shall mean: 
  

	 	(i)	Recipient’s rendering services while under the influence of alcohol or illegal drugs; 

  

	 	(ii)	Recipient’s performing any act of dishonesty, other than an act with immaterial consequences, in rendering services to the Company, including, without regard to materiality,
falsification of records, expense accounts or other reports; 

  

	 	(iii)	Recipient’s conviction, whether by judgment or plea, of any crime which constitutes a felony or which constitutes a misdemeanor involving violence, fraud, embezzlement or
theft; 

  

	 	(iv)	Recipient’s violation of any law or agreement which results in the entry of a judgment or order enjoining or preventing Recipient from such activities as are essential for
Recipient to perform services for the Company; 

  

	 	(v)	Recipient’s violation of any of the Company’s policies which provide for termination of employment as a possible consequence of such violation; 

 

	 	(vi)	conduct engaged in by Recipient which is injurious (other than to an immaterial extent) to the Company; 

  

	 	(vii)	the Company’s receipt of reliable information from any source of Recipient’s entering into or intending to enter into competition with the Company; or

	 	(viii)	refusal to perform such duties as may be delegated or assigned to Recipient, consistent with the Recipient’s position, by his or her supervisor. 

 (c) “CDI Stock” means CDI Corp. common stock, par value $.10 per share. 
 (d) “Committee” means the Compensation Committee of the Board or its successor. 
 (e) “Company”, as the context requires, means CDI Corp., CDI Corp. and its subsidiaries, or the individual subsidiary of CDI Corp. which
employs or retains the Recipient. 
 (f) “Date of Exercise” means the date on which the notice of exercise required by
Section 6 below is received by the Company. 
 (g) “Date of Grant” means [date]. 
 (h) “Disability” means a physical, mental or other impairment within the meaning of Section 22(e)(3) of the Internal Revenue Code of 1986,
as amended. 
 (i) “Exercise Price” means $[price], the Fair Market Value of CDI Stock on the Date of Grant.

 (j) “Fair Market Value” means the closing price of actual sales of CDI Stock on the New York Stock Exchange composite tape on a
given date or, if there are no such sales on such date, the closing price of CDI Stock on such Exchange on the last preceding date on which there was a sale. 
 (k) “Grant” means the grant of SAR’s to the Recipient which is described in Section 1 of this Agreement. 
 (l) “Plan” means the CDI Corp. 2004 Omnibus Stock Plan. 
 (m) “Retirement” means the
Recipient’s leaving the employ of the Company: 
  

	 	(i)	on or after the date that Recipient satisfies one of the following combinations of age and years of service with the Company: 

  

	 	•	60 years of age and 20 years of service; 

  

	 	•	62 years of age and 15 years of service; or 

  

	 	•	65 years of age and 5 years of service; or 

  

	 	(ii)	at such earlier date as may be approved by the Committee, in its sole discretion. 

  

 -2- 

 (n) “Termination Date” means the earliest of the following: 
  

	 	(i)	seven years following the Date of Grant; 

  

	 	(ii)	the date on which the Recipient’s employment or engagement with the Company is terminated by the Company for Cause; 

  

	 	(iii)	the date two weeks after the date on which the Recipient’s employment or engagement with the Company is terminated through the Recipient’s resignation or by the Company
for reasons other than for Cause; or 

  

	 	(iv)	the date six months after the date on which the Recipient employment or engagement with the Company is terminated as a result of the Recipient’s death, Disability or
Retirement. 

 3. Value of the SARs. The SAR’s shall entitle the Recipient, upon exercise of the SAR’s, to receive from the
Company an amount, payable in shares of CDI Stock, equal to: (i) the excess of the Fair Market Value on the date of exercise over the Exercise Price, multiplied by (ii) the number of SAR’s being exercised. The number of shares of CDI
Stock payable to the Recipient will be decreased in accordance with Section 7 below regarding tax withholding. 
 4. Period of Exercise. No
SAR’s shall be exercisable unless they have vested in accordance with Section 5 hereof. If vested, the SAR’s may be exercised at any time after vesting until the Termination Date. No SAR’s shall be exercisable on or after the
Termination Date. 
 5. Vesting. The SAR’s will vest at the rate of 20% per year on each of the first five anniversaries of the Date of
Grant. If the Recipient’s employment with the Company terminates as a result of death, Disability or Retirement, any then-unvested SAR’s will vest as of the date of such event. 
 6. Manner of Exercise. The SAR’s shall be exercisable by a written notice from the Recipient to the Company’s senior Human Resources executive, which shall state the number of SAR’s being
exercised. However, the Company may at any time hereafter notify the Recipient of a web-based or other method of exercising SAR’s, which other method may supplement or replace the previously-described written notice as the required method of
exercising the SAR’s. The SAR’s granted to the Recipient may be exercised in whole or in part. The SAR’s can only be exercised as to whole numbers of SAR’s. 
 7. Tax Withholding. The number of shares of CDI Stock to be delivered to the Recipient upon exercise of the SAR’s shall be reduced by the number of shares having a Fair Market Value equal to all taxes
(including, without limitation, federal, state, local or foreign income or payroll taxes) required by law to be withheld in connection with the exercise of the SAR’s. The portion of any shares of CDI Stock withheld pursuant to the applicable
tax laws shall be determined by using the Fair Market Value of CDI Stock on the last trading day immediately prior to the Date of Exercise. 
 8.
Nontransferablity of SAR’s. The SAR’s may not be transferred, in whole or in part, except (a) by will or the applicable laws of descent and distribution or (b) with the prior written approval of the Committee, to the
spouse or descendant of the Recipient or a trust for the benefit of the spouse or descendants. 
  

 -3- 

 9. Stock Ownership Requirements. If the Recipient is subject to any stock ownership requirements imposed by the
Company, those requirements may limit the Recipient’s ability to sell or otherwise transfer some or all of the shares of CDI Stock acquired by the Recipient through the exercise of the SAR’s. 
 10. Cancellation of SAR’s and Repayment of Gains. Notwithstanding any other provision of this Agreement, if the Committee determines that the Recipient has
entered into or intends to enter into competition with the Company or any of its subsidiaries, the Committee may, in its discretion, at any time during the term of the non-competitive covenant, if any, in the employment agreement, engagement
agreement, “covenants and agreements” or similar document between the Recipient and the Company which is being violated by such competition, cancel the outstanding SAR’s granted to the Recipient and/or require the Recipient to pay to
the Company an amount equal to any gains derived from the exercise of any SAR’s previously granted to and exercised by the Recipient during the one-year period prior to the termination of the Recipient’s employment or engagement with the
Company. 
 11. Securities Laws. The Committee may from time to time impose any conditions on the exercise of the SAR’s as it deems necessary or
advisable to ensure that all SAR’s granted under the Plan, and the exercise thereof, satisfy Rule 16b-3 (or any similar rule) of the Securities and Exchange Commission. Such conditions may include, without limitation, the partial or complete
suspension of the right to exercise the SAR’s. The Company may also condition delivery of certificates for shares of CDI Stock upon the prior receipt from the Recipient of any undertakings that it determines are required to ensure that the
certificates are being issued in compliance with federal and state securities laws. 
 12. Rights Prior to Issuance of Certificates. Neither the
Recipient nor any person to whom the Recipient’s rights shall have passed by will or by the laws of descent and distribution shall have any of the rights of a shareholder with respect to any shares of CDI Stock issuable upon exercise of the
SAR’s until the date of issuance to the Recipient of a certificate for such shares. 
 13. SAR’s Do Not Affect Employment Relationship. This
Grant shall not confer upon the Recipient any right to continue in the employ or service of the Company, nor interfere in any way with the right of the Company to terminate the employment of the Recipient at any time. 
 14. Interpretation. The Committee shall have the sole power to interpret this Agreement and to resolve any disputes arising hereunder. 
 15. Acknowledgement. The Recipient acknowledges receipt of a copy of the Plan and certain information related thereto and represents that he or she is familiar
with the terms and provisions thereof, and hereby accepts this Agreement subject to all of the terms and provisions of the Plan. The Recipient has reviewed the Plan and this Agreement in their entirety, has had an opportunity to obtain the advice of
independent counsel prior to executing this Agreement and fully understands all provisions relating to this Agreement. The Recipient hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Committee with
respect to any questions arising under the Plan or this Agreement. In addition, by entering into this Agreement and accepting this Grant, the Recipient acknowledges that: (a) the Grant is a one-time benefit and does not create any contractual
or other right to receive future grants, awards or other benefits in lieu of grants; (b) the Recipient’s participation in the Plan is voluntary; (c) this Grant is not part of 
  

 -4- 

 normal or expected compensation for any purpose, including without limitation for calculating any benefits, severance,
termination, bonuses, retirement benefits or similar payments; and (d) the future value of CDI Stock is unknown and cannot be predicted, and the Recipient is not, and will not, rely on any representation by the Company or any of its personnel
regarding the future value of CDI Stock. 
 16. Execution of this Agreement. If the Recipient does not sign and return this Agreement, the Company is
not obligated to provide the Recipient with any benefit hereunder and may refuse to issue shares of CDI Stock to the Recipient in connection with this Grant. If the Recipient receives any shares of CDI Stock in connection with this Grant but has not
signed and returned this Agreement, he or she will be deemed to have accepted and agreed to the terms set forth herein. 
  

							
	CDI CORP.	 	RECIPIENT
				
	By:	 	  
	 	Signature:	 	  

		 		 	Print Name:	 	  

		 		 	Date:	 	  

  

 -5-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00106-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00106-of-00352.parquet"}]]